Glytas M 30mg/500mg Tablet ER
Prescription Required
Introduction of Glytas M Tablet ER
Glytas M 30mg/500mg Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glytas M 30mg/500mg Tablet ER is used in the treatment of type 2 diabetes mellitus . It is a combination medicine that can control blood sugar better than single medication. It should be used along with a proper diet and regular exercise for best results. Hypoglycemia (low blood sugar level) may occur as a side effect and it should be taken with food to avoid upset stomach.
Glytas M 30mg/500mg Tablet ER is used in the treatment of type 2 diabetes mellitus . It is a combination medicine that can control blood sugar better than single medication. It should be used along with a proper diet and regular exercise for best results. Hypoglycemia (low blood sugar level) may occur as a side effect and it should be taken with food to avoid upset stomach.
Uses of Glytas M Tablet ER
Benefits of Glytas M Tablet ER
In Treatment of Type 2 diabetes mellitus
Glytas M 30mg/500mg Tablet ER is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It also improves the body’s response to the hormone insulin, which is responsible for regulating blood glucose (sugar) levels in our body. The insulin helps to lower your blood glucose levels and prevents them from rising after taking meals.
You should keep taking it for as long as it is prescribed. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
You should keep taking it for as long as it is prescribed. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
Side effects of Glytas M Tablet ER
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glytas M
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Diarrhea
- Flatulence
How to use Glytas M Tablet ER
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glytas M 30mg/500mg Tablet ER is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Glytas M 30mg/500mg Tablet ER.
Pregnancy
CONSULT YOUR DOCTOR
Glytas M 30mg/500mg Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Glytas M 30mg/500mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Glytas M 30mg/500mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glytas M 30mg/500mg Tablet ER may be needed. Please consult your doctor.
Use of Glytas M 30mg/500mg Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of Glytas M 30mg/500mg Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
Glytas M 30mg/500mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glytas M 30mg/500mg Tablet ER may be needed. Please consult your doctor.
Glytas M 30mg/500mg Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Glytas M 30mg/500mg Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
What if you forget to take Glytas M Tablet ER?
If you miss a dose of Glytas M 30mg/500mg Tablet ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Glytas M 30mg/500mg Tablet ER
₹7.67/Tablet ER
Euclide M 30 OD Tablet ER
Alkem Laboratories Ltd
₹8.1/tablet er
6% costlier
Diabend-MEX 30 Tablet ER
Bal Pharma Ltd
₹9.65/tablet er
26% costlier
Glycinorm-M 30 OD Tablet ER
Ipca Laboratories Ltd
₹8.74/tablet er
14% costlier
Glizid-M XR 30 Tablet
Panacea Biotec Ltd
₹7.62/tablet er
1% cheaper
Flisur 30mg/500mg Tablet ER
Retra Life Science Pvt Ltd
₹7.9/tablet er
3% costlier
Quick tips
Glytas M Tablet ER
- Monitor your blood sugar level regularly while you are taking this medicine.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic.
- Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glytas M 30mg/500mg Tablet ER may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
FAQs
Glytas M Tablet ER
What is Glytas M 30mg/500mg Tablet ER?
Glytas M 30mg/500mg Tablet ER is a combination of two medicines: Gliclazide and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Gliclazide lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of Type 1 DM.
What are the possible side effects of Glytas M 30mg/500mg Tablet ER?
The use of Glytas M 30mg/500mg Tablet ER is associated with common side effects. These side effects may include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, headache and upper respiratory tract infection. Its use can also lead to serious but rare side effects like lactic acidosis. On long-term use, it can also lead to vitamin B12 deficiency.
Can the use of Glytas M 30mg/500mg Tablet ER cause hypoglycemia?
Yes, the use of Glytas M 30mg/500mg Tablet ER can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of blood sugar level is important. Always keep glucose tablets, honey or fruit juice with you.
Can the use of Glytas M 30mg/500mg Tablet ER cause lactic acidosis?
Yes, the use of Glytas M 30mg/500mg Tablet ER can lead to lactic acidosis. It is a medical emergency which is caused by increased levels of lactic acid in the blood. It is also known as MALA (Metformin associated lactic acidosis). It is a rare side effect associated with the use of metformin. It is avoided in patients with underlying kidney disease, old age patients or who take large amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feeling of cold in arms and legs, difficulty in breathing, nausea, vomiting, stomach pain or slow heart rate. If you have these symptoms, stop taking Glytas M 30mg/500mg Tablet ER and immediately consult your doctor.
Can the use of Glytas M 30mg/500mg Tablet ER lead to Vitamin B12 deficiency?
Yes, the use of Glytas M 30mg/500mg Tablet ER can cause vitamin B12 deficiency on long-term use. The deficiency occurs as the medicine interferes with absorption of vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems and the patient can have tingling sensation and numbness in hands and feet, weakness, urinary problems, change in mental status and difficulty in maintaining balance (ataxia). To avoid such problems, some researchers suggest an intake of vitamin B12 from outside sources at least once every year.
Are there any specific conditions in which Glytas M 30mg/500mg Tablet ER should not to be taken?
The use of Glytas M 30mg/500mg Tablet ER should be avoided in patients with known allergy to any of the component or excipients of this medicine. It is also avoided in patients with moderate to severe kidney disease or with underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glytas M 30mg/500mg Tablet ER?
No, it is not safe to take alcohol along with Glytas M 30mg/500mg Tablet ER. It may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Gottwald-Hostalek U, Schlachter J, Geloneze B. Combination Therapy with Metformin plus Gliclazide in Patients with Type 2 Diabetes. J Dia Res Ther. 2016;2(3). [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. [Accessed 08 Apr. 2019] (online) Available from:
- Gliclazide+Metformin [Product Monograph]. Solan, Himachal Pradesh: Panacea Biotec Limited; 2019. [Accessed 23 Sept. 2021] (online) Available from:
- American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1): S98-S110. [Accessed 23 Sept. 2021] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 13 Mar. 2019] (online) Available from:
Marketer details
Name: Tas Med India Pvt Ltd
Address: Plot No. 45, N.T.M., Sector -26, Chandigarh
Country of origin: India
Lab tests offered by us
Related/Popular tests
67 people viewed this recentlyMRP
₹115
Inclusive of all taxes
15.0 tablet er in 1 strip
SOLD OUT